NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIDDK E-162-1991-0-PCT-02 No_Patent_Title PCT PCT PCT/US93/001936 Expired
NIDDK E-162-1991-0-JP-05 EPIBATIDINE DERIVATIVES, COMPOSITIONS AND METHODS OF TREATING PAIN JP National Stage 515870/1993 Abandoned
NIDDK E-162-1991-0-EP-04 EPIBATIDINE DERIVATIVES, COMPOSITIONS AND METHODS OF TREATING PAIN EP National Stage 93907013.2 Abandoned
NCI E-051-1990-0-US-16 TREATMENT OF HUMAN RETROVIRAL INFECTIONS WITH 2', 3'-DIDEOXYINOSINE US FWC 08/026,188 5376642 Expired PDF
NIBIB E-032-1992-0-GB-11 METHOD TO EHNANCE THE SENSITIVITY OF MRI FOR MAGNETIC SUSCEPTIBILITY EFFECTS GB EP 93906182.6 Expired
NIBIB E-032-1992-0-IT-03 METHOD TO EHNANCE THE SENSITIVITY OF MRI FOR MAGNETIC SUSCEPTIBILITY EFFECTS IT EP 93906182.6 Expired
NIBIB E-032-1992-0-NL-12 METHOD TO EHNANCE THE SENSITIVITY OF MRI FOR MAGNETIC SUSCEPTIBILITY EFFECTS NL EP 93906182.6 Expired
NIBIB E-032-1992-0-ES-04 METHOD TO EHNANCE THE SENSITIVITY OF MRI FOR MAGNETIC SUSCEPTIBILITY EFFECTS ES EP 93906182.6 Expired
NIBIB E-032-1992-0-EP-06 METHOD TO EHNANCE THE SENSITIVITY OF MRI FOR MAGNETIC SUSCEPTIBILITY EFFECTS EP National Stage 93906182.6 Expired
NIBIB E-032-1992-0-DE-05 METHOD TO EHNANCE THE SENSITIVITY OF MRI FOR MAGNETIC SUSCEPTIBILITY EFFECTS DE EP 93906182.6 Expired
NIBIB E-032-1992-0-FR-07 METHOD TO EHNANCE THE SENSITIVITY OF MRI FOR MAGNETIC SUSCEPTIBILITY EFFECTS FR EP 93906182.6 Expired
NIBIB E-032-1992-0-PCT-02 METHOD TO EHNANCE THE SENSITIVITY OF MRI FOR MAGNETIC SUSCEPTIBILITY EFFECTS PCT PCT PCT/US93/001609 Expired
NIDA E-172-1993-3-US-01 Purified Opioid Receptor US CIP 08/026,140 Abandoned
NIBIB E-032-1992-0-JP-08 METHOD TO EHNANCE THE SENSITIVITY OF MRI FOR MAGNETIC SUSCEPTIBILITY EFFECTS JP National Stage 5-515033 Abandoned
NIBIB E-032-1992-0-CA-10 METHOD TO EHNANCE THE SENSITIVITY OF MRI FOR MAGNETIC SUSCEPTIBILITY EFFECTS CA National Stage 2131018 Abandoned
NIBIB E-032-1992-0-AU-09 METHOD TO EHNANCE THE SENSITIVITY OF MRI FOR MAGNETIC SUSCEPTIBILITY EFFECTS AU National Stage 37307/93 Abandoned
NCI E-162-1989-1-US-01 MDR1 RETROVIRAL PLASMID US ORD 08/025,326 5654187 Expired PDF
NIAID E-220-1988-0-US-02 CYTOTOXIC AGENT AGAINST SPECIFIC VIRUS INFECTION US CON 08/022,095 5428143 Expired PDF
NCI E-062-1990-0-US-02 MOLECULAR CLONES OF HIV-1 VIRAL STRAINS MN-ST1 AND BA-L, AND USES THEREOF US FWC 08/022,835 5420030 Expired PDF
NIAID E-220-1988-0-US-03 CYTOTOXIC AGENT AGAINST SPECIFIC VIRUS INFECTION US DIV 08/022,182 Abandoned
NIDDK E-202-1991-0-US-04 N-[Arylethy]-N-Alkyl-2-(1-Pyrrolidinyl)ethylamine Derivatives for CNS Disorders US CON 08/020,498 Abandoned
NCI E-183-1990-0-US-03 Screening Test That Identifies Individuals at Increased Risk for the Development of Lymphoid Leukemia and Lymphoma US FWC 08/020,462 Abandoned
US
NCI E-317-1984-0-US-05 Antibody directed against HIV-1 P25 antigen US DIV 08/019,297 6600023 Expired PDF
NCI E-116-2007-3-US-03 Self-assembled, Defective, Non-self Propagating Lentivirus Particles US DIV 08/018,344 5631154 Expired PDF
NCI E-063-1992-0-AU-03 NOVEL ANTITUMOR COMPOUND; COMPOSITIONS AND METHOD OF USE AU National Stage 37738/93 Abandoned
NINDS E-118-1991-1-PCT-02 SEQUENCES CHARACTERISTIC OF HUMAN GENE TRANSCRIPTION PRODUCT PCT PCT PCT/US93/01294 Expired
NCI E-063-1992-0-PCT-02 No_Patent_Title PCT PCT PCT/US1993/001283 Expired
NCI E-063-1992-0-EP-05 NOVEL ANTITUMOR COMPOUND; COMPOSITIONS AND METHOD OF USE EP National Stage 93906963.9 Abandoned
NCI E-063-1992-0-JP-06 NOVEL ANTITUMOR COMPOUND; COMPOSITIONS AND METHOD OF USE JP National Stage 514303/93 Abandoned
NCI E-169-1990-0-EP-04 ANTI-HIV ACTIVITY OF LIPOSOMAL NYSTATIN AND AMPHOTERICIN B EP National Stage 93904286.9 Abandoned
NCI E-063-1992-0-CA-04 NOVEL ANTITUMOR COMPOUND; COMPOSITIONS AND METHOD OF USE CA National Stage 2129956 Abandoned
NCI E-317-1984-0-US-10 HUMAN IMMUNODEFICIENCY VIRUSES ASSOCIATED WITH AIDS, A DIAGNOSTIC METHOD FOR AIDS AND PRE-AIDS, A KIT THEREFOR US CON 08/016,224 Abandoned
NCI E-296-2005-1-US-01 5-aminoflavone Derivatives US ORD 08/014,696 Abandoned
NCI E-119-1991-2-JP-05 MET AND HGF FUNCTION IN HEMATOPOIESIS JP National Stage 514113/93 Abandoned
NCI E-119-1991-2-CA-02 MET AND HGF FUNCTION IN HEMATOPOIESIS CA National Stage 2129423 Abandoned
NCI E-119-1991-2-AU-03 MET AND HGF FUNCTION IN HEMATOPOIESIS AU National Stage 35996/93 Abandoned
NCI E-119-1991-2-PCT-01 HEPATIC GROWTH FACTOR RECEPTOR PCT PCT COMB PCT/US93/00824 Expired
NHLBI E-009-1992-0-PCT-02 No_Patent_Title PCT PCT PCT/US93/000889 Expired
NCI E-093-1995-1-IL-22 CHIMERIC RECEPTOR GENES AND CELLS TRANSFORMED THEREWITH IL ORD 104570 Expired
NCI E-084-1991-0-AU-03 AAMP-1 AU National Stage 34828/93 Abandoned
NCI E-084-1991-0-PCT-02 Aamp-1, a protein with local homologies to hiv-1 env and nef proteins PCT PCT PCT/US93/000601 Expired
NCI E-084-1991-0-EP-05 AAMP-1 A Protein with Local Homologies to HIV-1 ENV and NEF Protein EP National Stage 93903648.9 Abandoned
NCI E-084-1991-0-JP-06 AAMP-1 JP National Stage 5-513353 Abandoned
NCI E-084-1991-0-CA-04 AAMP-1, A PROTEIN WITH LOCAL HOMOLOGIES TO HIV-1 ENV AND NEF PROTEINS CA National Stage 2128879 Abandoned
NCI E-347-1986-0-AU-18 MACROCYCLIC CHELATES (AS AMENDED) AU DIV 32108/93 Abandoned
NIDDK E-047-1992-4-PCT-01 No_Patent_Title PCT PCT COMB PCT/US93/000466 Abandoned
NHLBI E-096-1991-1-US-02 Internal Initiation of Translation in Retroviral Vectors US FWC 08/009,338 6319707 Abandoned PDF
NCI E-142-1990-0-CA-22 AUTOTAXIN: MOTILITY STIMULATING PROTEIN USEFUL IN CANCER DIAGNOSIS AND THERAPY CA National Stage 2128215 Expired
NCI E-142-1990-0-BE-07 AUTOTAXIN: MOTILITY STIMULATING PROTEIN USEFUL IN CANCER DIAGNOSIS AND THERAPY BE EP 93903044.1 Expired